Mentioned in ?
References in periodicals archive ?
The Pharma division of the company launched several new products namely: Lamisil - for treatment of regular and tough fungal infections of the skin and nails, Exoderil - antifungal cream and solution and Leucomax - a granulocyte Macrophage Colony Stimulating Factory which is a major breakthrough in various pathological conditions and an adjutant to cancer chemotherapy during the year under review.
Leucomax, which stimulates white blood cell production for AIDS victims, will go on sale this year.
During his time at Schering-Plough, Guy-Charles managed the sales and marketing team for Intron A and Leucomax in France after having been international product manager for Intron A based in the USA.